Kathleen M. Neuzil, MD, MPH

Kathleen M. Neuzil, MD, MPH, is vice president of the National Foundation for Infectious Diseases (NFID). She is the Myron M. Levine Professor in Vaccinology, professor of medicine and pediatrics, and the director of the Center for Vaccine Development and Global Health (CVD) at the University of Maryland School of Medicine. An internationally recognized research scientist and advocate in the field of vaccinology, she has played a central role in the domestic and global response to COVID-19. Throughout her career, Neuzil has conducted clinical and epidemiologic studies on vaccine-preventable diseases including influenza, rotavirus, human papillomavirus, Japanese encephalitis, and typhoid. As a co-principal investigator of the National Institutes for Health-funded Leadership Group for the Vaccine and Treatment Evaluation Unit network, she is part of the strategic team evaluating COVID-19 vaccines and therapeutics in the US and was part of the study team who designed the first COVID-19 clinical vaccine trial in the US. The CVD is likewise participating in COVID-19 treatment and post-exposure prophylaxis trials. She also directs TyVAC, the Typhoid Vaccine Acceleration Consortium, with the goal to accelerate the introduction of typhoid conjugate vaccines into low-resource countries. She is a member of the World Health Organization Strategic Advisory Group of Experts on Immunization and the prestigious National Academy of Medicine. Previously, she served on the US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices.